Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002437310 | SCV002744773 | uncertain significance | Inborn genetic diseases | 2018-01-23 | criteria provided, single submitter | clinical testing | The p.H37P variant (also known as c.110A>C), located in coding exon 2 of the PLP1 gene, results from an A to C substitution at nucleotide position 110. The histidine at codon 37 is replaced by proline, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Molecular Diagnostics Lab, |
RCV004595664 | SCV005088445 | likely pathogenic | Pelizaeus-Merzbacher disease | 2024-06-14 | criteria provided, single submitter | clinical testing | This missense variant (c.110T>C, p.His37Pro) has not been observed in population databases (gnomAD). It has not been described in the literature. Variant prediction programs suggest a deleterious effect on the PLP1 protein, but no functional studies have been published. |